Biblio Discovery — Demo Discovery Service

4 results for "Stephan Martin"

Showing 1–4 · 0.86 seconds · RSS

  1. Journal Article Full text

    Does task delegation to non-physician health professionals improve quality of diabetes care? Results of a scoping review

    Sanas Mirhoseiny; Tjarko Geelvink; Stephan Martin et al.

    PLOS ONE, Vol. 14 No. 10 · 2019 · English · PLOS Scopus

    Objective: As a result of unhealthy lifestyles, reduced numbers of healthcare providers are having to deal with an increasing number of diabetes patients. In light of this shortage of physicians and nursing staff, new concepts of care are needed. The aim of this scoping review is to review the…

  2. Journal Article Full text

    Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial

    Stephan Martin; Christian Herder; Nanette C. Schloot et al.

    PLoS ONE, Vol. 6 No. 3 · 2011 · English · PLOS Scopus

    Background: Recent evidence suggests that the lipid-lowering agent atorvastatin is also a potent immunomodulator. The aim of this study was to investigate the possible effect of atorvastatin on the decline of residual beta cell function in recent-onset type 1 diabetes. Methods and Findings: The…

  3. Journal Article Full text

    The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial)

    Hubert Kolb; Kathrin Lückemeyer; Tim Heise et al.

    PLoS ONE, Vol. 8 No. 8 · 2013 · English · PLOS Scopus

    Background: The hypothesis was tested that the systemic immune milieu in recent-onset type 1 diabetes is associated with residual beta cell function and other metabolic patient characteristics. Methods and Findings: All patients (n = 89, 40% female) of the Diabetes and Atorvastatin (DIATOR) Trial…

  4. Journal Article Full text

    Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial)

    Alexander Strom; Hubert Kolb; Stephan Martin et al.

    PLoS ONE, Vol. 7 No. 3 · 2012 · English · PLOS Scopus

    Background: A recent randomized placebo-controlled trial of the effect of atorvastatin treatment on the progression of newly diagnosed type 1 diabetes suggested a slower decline of residual beta cell function with statin treatment. Aim of this secondary analysis was to identify patient subgroups…